Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 33% ± 12% | |
glutamatergic neuron | 7 studies | 37% ± 22% | |
fibroblast | 6 studies | 31% ± 13% | |
cardiac muscle cell | 5 studies | 32% ± 8% | |
astrocyte | 5 studies | 31% ± 19% | |
GABAergic neuron | 5 studies | 37% ± 16% | |
smooth muscle cell | 5 studies | 25% ± 9% | |
epithelial cell | 4 studies | 26% ± 4% | |
adipocyte | 4 studies | 25% ± 2% | |
Mueller cell | 4 studies | 61% ± 24% | |
ciliated cell | 4 studies | 23% ± 9% | |
glomerular endothelial cell | 3 studies | 21% ± 4% | |
GABAergic interneuron | 3 studies | 22% ± 4% | |
myofibroblast cell | 3 studies | 24% ± 8% | |
interneuron | 3 studies | 34% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1413.76 | 245 / 245 | 99% | 10.64 | 496 / 502 |
kidney | 100% | 1148.79 | 89 / 89 | 97% | 14.51 | 877 / 901 |
lung | 99% | 821.88 | 575 / 578 | 91% | 9.86 | 1046 / 1155 |
thymus | 100% | 1194.68 | 653 / 653 | 89% | 8.15 | 540 / 605 |
breast | 93% | 574.53 | 429 / 459 | 91% | 7.80 | 1012 / 1118 |
uterus | 100% | 1108.61 | 170 / 170 | 80% | 12.42 | 369 / 459 |
ovary | 98% | 850.76 | 177 / 180 | 81% | 5.68 | 349 / 430 |
esophagus | 99% | 1376.13 | 1427 / 1445 | 78% | 8.69 | 143 / 183 |
adrenal gland | 98% | 560.05 | 254 / 258 | 78% | 6.98 | 180 / 230 |
brain | 76% | 655.93 | 2017 / 2642 | 96% | 7.27 | 675 / 705 |
bladder | 100% | 1058.14 | 21 / 21 | 64% | 5.76 | 324 / 504 |
stomach | 81% | 443.16 | 290 / 359 | 66% | 3.74 | 188 / 286 |
intestine | 87% | 583.26 | 845 / 966 | 55% | 2.88 | 291 / 527 |
skin | 44% | 151.33 | 787 / 1809 | 69% | 11.68 | 326 / 472 |
liver | 70% | 171.33 | 159 / 226 | 38% | 2.03 | 155 / 406 |
pancreas | 10% | 26.64 | 34 / 328 | 96% | 8.54 | 170 / 178 |
spleen | 99% | 667.03 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 775.68 | 1302 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 845.93 | 837 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 11.53 | 37 / 45 |
eye | 0% | 0 | 0 / 0 | 76% | 6.91 | 61 / 80 |
adipose | 74% | 347.71 | 887 / 1204 | 0% | 0 | 0 / 0 |
muscle | 60% | 156.73 | 482 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 2.68 | 16 / 29 |
peripheral blood | 0% | 0.40 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031641 | Biological process | regulation of myelination |
GO_0001657 | Biological process | ureteric bud development |
GO_0003417 | Biological process | growth plate cartilage development |
GO_0007165 | Biological process | signal transduction |
GO_0048566 | Biological process | embryonic digestive tract development |
GO_0035264 | Biological process | multicellular organism growth |
GO_0061351 | Biological process | neural precursor cell proliferation |
GO_0072089 | Biological process | stem cell proliferation |
GO_0021756 | Biological process | striatum development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0002068 | Biological process | glandular epithelial cell development |
GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
GO_2000647 | Biological process | negative regulation of stem cell proliferation |
GO_0022008 | Biological process | neurogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0048384 | Biological process | retinoic acid receptor signaling pathway |
GO_0048048 | Biological process | embryonic eye morphogenesis |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0055012 | Biological process | ventricular cardiac muscle cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1901363 | Molecular function | heterocyclic compound binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | RARB |
Protein name | RARB protein Retinoic acid receptor beta (Nuclear receptor subfamily 1 group B member 2) Retinoic acid receptor beta Retinoic acid receptor beta (RAR-beta) (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon) |
Synonyms | HAP NR1B2 hCG_26863 |
Description | FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence or presence of hormone ligand, acts mainly as an activator of gene expression due to weak binding to corepressors . The RXRA/RARB heterodimer can act as a repressor on the DR1 element and as an activator on the DR5 element . In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). . |
Accessions | ENST00000687676.1 [P10826-1] F1D8S6 ENST00000689700.1 Q6FHY0 ENST00000383772.9 [P10826-1] ENST00000330688.9 [P10826-2] A0A8I5KVN9 ENST00000690398.1 ENST00000692640.1 A0A8I5KXD0 A0A8I5KQX3 ENST00000455576.2 ENST00000691580.1 Q15299 ENST00000688892.1 [P10826-1] ENST00000479097.6 A0A8I5KWP3 Q86UC5 ENST00000693580.1 ENST00000685523.1 ENST00000693261.1 [P10826-3] A0A8I5KXT3 D6RBI3 A0A8I5KNZ0 A0A8I5KVP8 ENST00000687353.1 [P10826-1] ENST00000458646.2 [P10826-3] ENST00000686715.1 [P10826-1] Q5QHG3 ENST00000687083.1 A0A8I5KUH8 A0A8I5KVJ9 ENST00000383772 ENST00000437042.7 [P10826-3] A0A8I5KSR9 P10826 ENST00000691912.1 ENST00000480001.6 |